These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported Terminated||2006-006889-42||Exploratory, double blind placebo controlled, randomized, single cross-over study to evaluate the potential anti-oxidant action of Niaspan||2011-01-28||due-trials|
|Ongoing||2013-004406-25||Biomarkers identification of anti-TNF α agent’s efficacy in Ankylosing Spondylitis patients using a transcriptome analysis and mass spectrometry||not-yet-due|